Acute ocular hypertension disrupts barrier integrity and pump function in rat corneal endothelial cells.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Subject Terms:
    • Abstract:
      Acute ocular hypertension (AOH) frequently compromises corneal endothelial cell (CEC) function in clinical practice. This type of stress induces corneal oedema and a decrease in the corneal endothelial cell density (ECD). The anterior chamber of the right eye of Sprague-Dawley rats was irrigated with Balanced Salt Solution (BSS) for two hours, and the left eye served as a control to determine the time-dependent effects of AOH on endothelial cell morphology and function. The average intraocular pressure (IOP) increased to 82.6 ± 2.3 mmHg (normal range: 10.2 ± 0.4 mmHg) during anterior irrigation. Very soon after initiating irrigation, corneal oedema became evident and the cornea exhibited a significant increase in permeability to FITC-dextran. The peripheral ECD was significantly reduced, and the morphology of CECs became irregular and multiform. The structures of the zonula occludens-1 (ZO-1) and F-actin were severely disrupted. In addtion, Na,K-ATPase exhibited a dispersed expression pattern. Two days after irrigation, obvious CEC proliferation was observed, the ECD recovered to a normal level, and F-actin was dispersed throughout the cytoplasm. Seven days later, the CEC structure and function were nearly normalized. Based on the results obtained using this model, an acute IOP crisis exerts transient deleterious effects on CEC structure and function in rats.
    • References:
      Ophthalmology. 1982 Jun;89(6):596-9. (PMID: 7122040)
      Acta Ophthalmol (Copenh). 1979;57(6):1004-13. (PMID: 545996)
      J Glaucoma. 1997 Dec;6(6):377-83. (PMID: 9407366)
      Br J Ophthalmol. 2006 Mar;90(3):262-7. (PMID: 16488940)
      Prog Retin Eye Res. 2003 Jan;22(1):69-94. (PMID: 12597924)
      Cornea. 1997 May;16(3):314-8. (PMID: 9143804)
      Acta Ophthalmol (Copenh). 1975 Dec;53(6):839-55. (PMID: 813491)
      Invest Ophthalmol Vis Sci. 1986 Aug;27(8):1199-204. (PMID: 3733367)
      Invest Ophthalmol Vis Sci. 2006 May;47(5):1754-67. (PMID: 16638979)
      J Physiol. 1972 Feb;221(1):29-41. (PMID: 4259586)
      J Cell Biol. 1986 Sep;103(3):755-66. (PMID: 3528172)
      Mol Vis. 2010 Nov 11;16:2368-75. (PMID: 21139971)
      Invest Ophthalmol Vis Sci. 1988 Jun;29(6):940-8. (PMID: 2967259)
      Invest Ophthalmol Vis Sci. 2013 Oct 15;54(10):6735-44. (PMID: 24045986)
      Exp Eye Res. 2004 Mar;78(3):537-41. (PMID: 15106932)
      Acta Ophthalmol (Copenh). 1980 Apr;58(2):257-66. (PMID: 7395487)
      Prog Brain Res. 2008;173:583-90. (PMID: 18929136)
      Ophthalmologe. 2012 Jan;109(1):30-6. (PMID: 22274295)
      Br J Ophthalmol. 1980 Jul;64(7):537-43. (PMID: 7426569)
      J Glaucoma. 2006 Dec;15(6):482-5. (PMID: 17106359)
      Invest Ophthalmol Vis Sci. 1985 Sep;26(9):1191-201. (PMID: 2993191)
      Biochim Biophys Acta. 2008 Mar;1778(3):660-9. (PMID: 17854762)
      Am Fam Physician. 2007 Sep 15;76(6):829-36. (PMID: 17910297)
      J Glaucoma. 2012 Jan;21(1):12-6. (PMID: 21048505)
      Curr Eye Res. 1984 Feb;3(2):331-8. (PMID: 6705557)
      Invest Ophthalmol Vis Sci. 2013 Aug 09;54(8):5400-7. (PMID: 23821192)
      Am J Ophthalmol. 1982 Nov;94(5):610-6. (PMID: 7148942)
      Clin Exp Ophthalmol. 2003 Dec;31(6):492-5. (PMID: 14641156)
      Am J Ophthalmol. 1976 Apr;81(4):473-81. (PMID: 1266927)
    • Accession Number:
      0 (Actins)
      0 (Dextrans)
      0 (Zonula Occludens-1 Protein)
      0 (fluorescein isothiocyanate dextran)
      EC 7.2.2.13 (Sodium-Potassium-Exchanging ATPase)
      I223NX31W9 (Fluorescein-5-isothiocyanate)
    • Publication Date:
      Date Created: 20170802 Date Completed: 20190311 Latest Revision: 20191210
    • Publication Date:
      20221213
    • Accession Number:
      PMC5537405
    • Accession Number:
      10.1038/s41598-017-07534-9
    • Accession Number:
      28761172